# Inhibikase Therapeutics, Inc.: Form 8-K, filed Apr 14, 2025

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: 8-K
- Filed: 2025-04-14
- Accepted by EDGAR: Apr 14, 2025, 12:16 ET
- Period: 2025-04-11
- Accession: 0001193125-25-079656
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000119312525079656/d857709d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000119312525079656/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000119312525079656/d857709d8k.htm

Filed Apr 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-079656. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.